FIELD: medicine.
SUBSTANCE: invention relates to the use of GHRP-6 and its structural analogue as molecular adjuvants for vaccines. Vaccines can be used to prevent diseases caused by infectious agents, such as viruses, bacteria and ectoparasites that affect mammals, birds and aquatic organisms.
EFFECT: GHRP-6 and its analogue A233 are effective as adjuvants when combined with this antigen, as they enhance a specific immune response against it.
9 cl, 9 dwg, 3 tbl, 9 ex
Title | Year | Author | Number |
---|---|---|---|
VACCINE COMPOSITION FOR CONTROLLING INFESTATION WITH ECTOPARASITES | 2011 |
|
RU2585226C2 |
APPLICATION OF PACAP AS MOLECULAR ADJUVANT FOR VACCINES | 2012 |
|
RU2580294C2 |
AMINO-ACID SEQUENCES FOR CONTROL OF PATHOGEN | 2012 |
|
RU2636001C2 |
CHEMERICAL ANTIGENES FOR VACCINE AGAINST HEPATITIS C VIRUS | 2013 |
|
RU2639504C2 |
METHOD OF USE IN THERAPY | 2010 |
|
RU2579659C2 |
IMMUNOSTIMULATING OLIGONUCLEOTIDES | 2009 |
|
RU2477753C2 |
IMMUNOSTIMULATORY OLIGONUCLEOTIDES | 2012 |
|
RU2610690C2 |
ENHANCING IMMUNE RESPONSE AND TARGET FOCUS BY ANTIGENS AND/OR DRUG | 2008 |
|
RU2548685C2 |
IMMUNOGENIC COMPOSITION LHRH AND ITS USE IN SWINE | 2014 |
|
RU2745720C2 |
PEPTIDE VACCINE FOR PREVENTION AND IMMUNOTHERAPY OF DEMENTIA OF THE ALZHEIMER'S TYPE | 2013 |
|
RU2696566C2 |
Authors
Dates
2022-03-23—Published
2017-10-30—Filed